References
- WHO, COVID-19 and NCDs. World Health Organization; 2020. 5. Available from: https://www.who.int/docs/default-source/ncds/ncd-covid-19/for-web—rapid-assessment—29-may-2020-(cleared).pdf?sfvrsn=6296324c_14&download=true. Accessed November 16, 2021.
- Yang J, Zheng Y, Gou X. Prevalence of comorbidities and its effects in patients infected with SARS-CoV-2: a systematic review and meta-analysis. Int J Infect Dis. 2020;94:91–95. doi:10.1016/J.IJID.2020.03.017
- Nikoloski Z, Alqunaibet AM, Alfawaz RA, et al. Covid-19 and non-communicable diseases: evidence from a systematic literature review. BMC Public Health. 2021;21(1):1–9. doi:10.1186/S12889-021-11116-W
- Kataria I, Morris AMJ. Addressing chronic noncommunicable diseases is essential to strengthen urban resilience to communicable pandemic diseases. Cities Health. 2020:1–3. doi::10.1080/23748834.2020.1805280
- Zhen H, Li N, Li D, et al. Telemedicine During the COVID-19 Pandemic: experiences From Western China,”. J Med Internet Res. 2020;22(5):e19577. doi:10.2196/19577
- Bashshur R, Doarn CR, Frenk JM, Kvedar JC, Woolliscroft JO. Telemedicine and the COVID-19 Pandemic. Lessons Future. 2020;26(5):571–573. doi:10.1089/TMJ.2020.29040.RB
- Aj B. Exploring the adoption of telemedicine and virtual software for care of outpatients during and after COVID-19 pandemic. Ir J Med Sci. 2021;190(1). doi:10.1007/S11845-020-02299-Z
- Menon JC, Rakesh PS, John D, et al. What was right about Kerala’s response to the COVID-19 pandemic? Commentary Handling editor Seye Abimbola,”. BMJ Global Health. 2020;5(7):3212. doi:10.1136/bmjgh-2020-003212
- Vg C, Ay N, Taneja N. Telemedicine in India: where do we stand? J Family Med Primary Care. 2019;8(6):1872. doi:10.4103/JFMPC.JFMPC_264_19
- Dasgupta A, Deb S. Telemedicine: a new horizon in public health in India. Indian J Community Med. 2008;33(1):3. doi:10.4103/0970-0218.39234
- Barone MTU, Harnik SB, de Luca PV, et al. The impact of COVID-19 on people with diabetes in Brazil,”. Diabetes Res Clin Pract. 2020;166:108304. doi:10.1016/J.DIABRES.2020.108304
- Noorimotlagh Z, Jaafarzadeh N, Martínez SS, Mirzaee SA. A systematic review of possible airborne transmission of the COVID-19 virus (SARS-CoV-2) in the indoor air environment. Environ Res. 2021;193:110612. doi:10.1016/J.ENVRES.2020.110612
- Jnr BA. Use of Telemedicine and Virtual Care for Remote Treatment in Response to COVID-19 Pandemic. J Med Syst. 2020;44(7). doi:10.1007/S10916-020-01596-5
- Verma A, Rajput R, Verma S, Balania VKB, Jangra B. Impact of lockdown in COVID 19 on glycemic control in patients with type 1 Diabetes Mellitus. Diabetes Metab Syndr. 2020;14(5):1213. doi:10.1016/J.DSX.2020.07.016
- Khader MA, Jabeen T, Namoju R. A cross sectional study reveals severe disruption in glycemic control in people with diabetes during and after lockdown in India. Diabetes Metab Syndr. 2020;14(6):1579. doi:10.1016/J.DSX.2020.08.011
- Ghosh A, Arora B, Gupta R, Anoop S, Misra A. Effects of nationwide lockdown during COVID-19 epidemic on lifestyle and other medical issues of patients with type 2 diabetes in north India. Diabetes Metab Syndr. 2020;14(5):917. doi:10.1016/J.DSX.2020.05.044
- Sankar P, Ahmed WN, Mariam Koshy V, Jacob R, Sasidharan S. Effects of COVID-19 lockdown on type 2 diabetes, lifestyle and psychosocial health: a hospital-based cross-sectional survey from South India. Diabetes Metab Syndrome. 2020;14(6):1815–1819. doi:10.1016/J.DSX.2020.09.005
- Mahajan V, Singh T, Azad C. Using Telemedicine During the COVID-19 Pandemic. Indian Pediatr. 2020;1:658.
- Basu S. Non-communicable disease management in vulnerable patients during Covid-19. Indian J Med Ethics. 2020;V(2):103–105. doi:10.20529/IJME.2020.041
- Anthony Jnr B. Implications of telehealth and digital care solutions during COVID-19 pandemic: a qualitative literature review. Inform Health Soc Care. 2021;46(1):68–83. doi:10.1080/17538157.2020.1839467